Invention Grant
- Patent Title: Selective disruption of neoplastic cells via resonant harmonic excitation
-
Application No.: US15912359Application Date: 2018-03-05
-
Publication No.: US11229809B2Publication Date: 2022-01-25
- Inventor: David Reza Mittelstein , Morteza Gharib , Stefanie Heyden , Michael Ortiz , Mikhail G. Shapiro
- Applicant: California Institute of Technology
- Applicant Address: US CA Pasadena
- Assignee: California Institute of Technology
- Current Assignee: California Institute of Technology
- Current Assignee Address: US CA Pasadena
- Agency: KPPB LLP
- Main IPC: A61N7/00
- IPC: A61N7/00 ; A61M37/00 ; A61B8/08 ; A61B17/3205 ; A61B5/055 ; A61B18/00 ; A61B90/00 ; A61B17/00

Abstract:
Systems and methods for targeting specific cell types by selective application of ultrasonic harmonic excitation at a resonance frequency (“oncotripsy”) for the specific cell types are presented. The systems and the methods result in permeabilization, lysis, and/or death of the targeted specific cell types by using ultrasonic harmonic excitations that have a frequency and a pulse duration specifically tuned to disrupt nuclear membranes of the targeted specific cell types by inducing a destructive vibrational response therein while leaving non-targeted cell types intact. Target cells may be neoplastic.
Public/Granted literature
- US20180256922A1 Selective Disruption of Neoplastic Cells via Resonant Harmonic Excitation Public/Granted day:2018-09-13
Information query